Early research (Phase 1)Study completedNCT03454165What this trial is testingBNC105P Combined With IbrutinibWho this might be right forChronic Lymphocytic Leukemia Dartmouth-Hitchcock Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT01096992What this trial is testingFludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia M.D. Anderson Cancer Center 51
Not applicableWithdrawnNCT00770419What this trial is testingPerceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT05317936What this trial is testingPirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With VenetoclaxWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma M.D. Anderson Cancer Center 3
Early research (Phase 1)Looking for participantsNCT06208735What this trial is testingCLIC-2201 for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forB-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more British Columbia Cancer Agency 24
Early research (Phase 1)Study completedNCT00036257What this trial is testingDose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Astellas Pharma Inc 15
Testing effectiveness (Phase 2)UnknownNCT04648475What this trial is testingSafety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and LymphomaWho this might be right forLeukemia, B-cellLymphoma, B-Cell Chongqing Precision Biotech Co., Ltd 40
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Not applicableLooking for participantsNCT06821880What this trial is testingDeveloping a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID ProjectWho this might be right forChronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID) Medical University Innsbruck 120
Testing effectiveness (Phase 2)UnknownNCT06697990What this trial is testingCerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer PatientsWho this might be right forCarcinoma, Non-Small-Cell Lung Tianjin Medical University Cancer Institute and Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00006220What this trial is testingArsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Washington University School of Medicine 5
Early research (Phase 1)Study completedNCT01098188What this trial is testingLFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Laboratoire français de Fractionnement et de Biotechnologies 33
Testing effectiveness (Phase 2)Ended earlyNCT01612988What this trial is testingTreatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLLWho this might be right forB-cell Chronic Lymphocytic Leukemia (B-CLL) French Innovative Leukemia Organisation 74
Early research (Phase 1)Study completedNCT01732861What this trial is testingSafety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic LymphomaWho this might be right forLeukemia Lymphocytic Chronic B-Cell Celgene 20
Large-scale testing (Phase 3)Study completedNCT02242942What this trial is testingComparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic LeukemiaWho this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 445
Testing effectiveness (Phase 2)Study completedNCT01497496What this trial is testingOfatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma H. Lee Moffitt Cancer Center and Research Institute 29
Not applicableStudy completedNCT00569842What this trial is testingInvestigation of the Cylex® ImmuKnow® AssayWho this might be right forLeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more Indiana University 45
Not applicableLooking for participantsNCT06357754What this trial is testingTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary MalignancyWho this might be right forNon-Hodgkin LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT02213913What this trial is testingLenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more University of Chicago 55
Testing effectiveness (Phase 2)Study completedNCT02061761What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell MalignanciesWho this might be right forHematologic Neoplasms Bristol-Myers Squibb 106